pharmablog.in

SCHEDULE M – GMP – PART 6 (METERED-DOSE-INHALERS)

pharmablog.in / Guidelines / February 22, 2024 / GMP, SCHEDULE M

GOOD MANUFACTURING PRACTICES FOR METERED-DOSE-INHALERS (MDI)

SCHEDULE M – GMP – PART 6 (METERED-DOSE-INHALERS) Read More »

SCHEDULE M – GMP – PART 5 (TOPICAL PRODUCTS)

pharmablog.in / Guidelines / February 22, 2024 / GMP, SCHEDULE M

GOOD MANUFACTURING PRACTICES FOR TOPICAL PRODUCTS i.e. EXTERNAL PREPARATIONS (CREAMS, OINTMENTS, PASTES, MULSIONS, LOTIONS, SOLUTIONS, DUSTING POWDERS AND IDENTICAL PRODUCTS)

SCHEDULE M – GMP – PART 5 (TOPICAL PRODUCTS) Read More »

SCHEDULE M – GMP – PART 4 (ORAL LIQUIDS)

pharmablog.in / Guidelines / February 20, 2024 / GMP, ORAL LIQUIDS, SCHEDULE M

GOOD MANUFACTURING PRACTICES FOR ORAL LIQUIDS (SYRUPS, ELIXIRS, EMULSIONS AND SUSPENSIONS)

SCHEDULE M – GMP – PART 4 (ORAL LIQUIDS) Read More »

STANDARD SOLUTIONS FOR LIMIT TESTS

pharmablog.in / Quality control / February 20, 2024 / LIMIT TESTS, QC

Standard Solutions For Limit Tests Preparation | Limit Tests Solutions Preparation |

STANDARD SOLUTIONS FOR LIMIT TESTS Read More »

SCHEDULE M – GMP – PART 3 (PARENTERAL PREPARATIONS)

pharmablog.in / Guidelines / February 20, 2024 / GMP, PARENTERAL PREPARATIONS, SCHEDULE M

GOOD MANUFACTURING PRACTICES FOR STERILE PRODUCTS, PARENTERAL PREPARATIONS (SMALL VOLUME INJECTABLES AND LARGE VOLUME PARENTERALS) AND STERILE OPHTHALMIC PREPARATIONS.

SCHEDULE M – GMP – PART 3 (PARENTERAL PREPARATIONS) Read More »

SCHEDULE M – GMP – PART 2 (OSD)

pharmablog.in / Guidelines / February 1, 2024 / GMP, OSD, QC, SCHEDULE M

GOOD MANUFACTURING PRACTICES FOR ORAL SOLID DOSAGE FORMS (TABLETS AND CAPSULES)

SCHEDULE M – GMP – PART 2 (OSD) Read More »

Data Integrity – ALCOA+

pharmablog.in / Guidelines / January 28, 2024 / alcoa, alcoa+, data integrity

Data integrity is the fundamental principle of ensuring that data is accurate, reliable, and consistent throughout its entire lifecycle.

Data Integrity – ALCOA+ Read More »

What is CAPA – Corrective and preventative action

pharmablog.in / Guidelines / January 25, 2024 / CAPA, Corrective action and preventative action

Corrective and preventative action (CAPA) in pharma refers to the process of identifying, investigating, and addressing any issues or deviations that may have occurred during the production of pharmaceutical products.

What is CAPA – Corrective and preventative action Read More »